Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 83

The Intelligence Explosion is Coming

The race toward an imminent intelligence explosion has escalated from a sci-fi thought experiment into a high-stakes global debate.

Accelerating progress across model reasoning and compute infrastructure forces a critical question: is Artificial General Intelligence already arriving?

Silicon Valley insiders frequently claim human-level AI has passed us by, though critics warn these declarations are heavily warped by financial incentives.

If an AI system successfully achieves recursive self-improvement, the resulting technological singularity could compress centuries of human progress into mere hours.

A best-case takeoff promises staggering rewards like clean fusion energy, automated economic abundance, and radical medical breakthroughs that extend human lifespans indefinitely.

Silk sticker is noninvasive way to monitor babies’ health

In the neonatal intensive care unit, the most fragile patients in medicine are often the most heavily wired. Premature babies, some weighing less than a pound, can be tethered to a tangle of cables, monitors and sensors. Each blood draw to check sugar levels or electrolytes means another needle, another bandage, another moment of stress for an infant whose skin is still forming.

A team of researchers from Tufts University’s Silklab, Helmholtz Munich, Ludwig Maximilian University (LMU) Munich and the Technical University of Munich have developed a radically gentler alternative: a featherlight, silk-based sticker, smaller than a coin, that quietly reads four critical health signals at once just by changing color.

The work, published in ACS Sensors, describes a wearable patch that captures temperature, pH, sodium and glucose from the wisps of fluid that pass naturally through a baby’s still-developing skin. An AI system reads the patch’s color shifts through any standard camera, even in the dim, humid, hard-to-photograph environment of an incubator, and translates them into precise numbers a clinician can act on.

Abstract: 1 Holman Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA

1 Holman Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.

2Keenan Centre for Biomedical Research, St. Michael’s Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.

3Department of Foundations of Medicine, Diabetes and Obesity Research Center, New York University Grossman Long Island School of Medicine, Mineola, New York, USA.

Google Just Revealed a 100% Stable Quantum Computer — AI is Obsolete

Google has unveiled a quantum computing breakthrough that could reshape the future of artificial intelligence, cryptography, medicine, and global technology. But does this really mean AI is becoming obsolete?

In this video, we break down Google’s Willow quantum chip, the revolutionary error-correction milestone it achieved, and why experts believe this could be one of the biggest advances in computing history. We also explain what the headlines get wrong, how quantum computing actually differs from AI, and why the future is likely to be a combination of both technologies rather than a competition.

You’ll discover:
• What makes Google’s Willow chip so significant.
• How quantum computers differ from classical AI
• Why the \.

Inducing cell death in pancreatic cancer cells

Researchers have discovered a previously unknown mechanism that makes most pancreatic cancer cells susceptible to a form of programmed cell death. The team showed that cancer cells with mutations in the KRAS gene develop a vulnerability which can be used to eliminate tumor cells in preclinical models. The findings open up new perspectives for treating pancreatic cancer. The study was published in the journal Nature Communications.

Pancreatic cancer is one of the most aggressive forms of cancer and has so far shown only limited response to available treatments. In approximately 90 percent of cases, these tumors carry mutations in the KRAS gene that drive cancer growth. Due to the ageing population and the lack of effective therapies, physicians, clinicians, and researchers expect pancreatic carcinoma to become one of the leading causes of cancer-related deaths worldwide in the coming years. With the discovery of this newly identified vulnerability, a therapeutically promising approach has now been identified for treating this disease following future clinical trials.

The researchers discovered that KRAS-mutated tumor cells continuously activate signals from the innate immune system. This primes the cancer cells for an inflammatory form of cell death known as necroptosis. In order to survive, tumor cells rely heavily on the protein caspase-8, which usually inhibits necroptosis. If caspase-8 is blocked, the tumor cells die. “KRAS-mutated tumors have a previously unknown Achilles heel,” says the senior author of the study. “By switching off the tumor cells’ defence mechanisms, we can significantly kill these tumors.”

Vascular Control Of Aging And Regeneration (Featuring Anjali Kusumbe, PhD)

Join us on Patreon! / michaellustgartenphd.

Discount Links/Affiliates:
Blood testing (where I get the majority of my labs, for those who blood test with Quest): https://www.ultalabtests.com/partners… those who blood test with LabCorp: https://www.anrdoezrs.net/click-10161… At-Home Metabolomics: https://www.iollo.com?ref=michael-lus… Use Code: CONQUERAGING At Checkout Clearly Filtered Water Filter: https://get.aspr.app/SHoPY Epigenetic, Telomere Testing: https://trudiagnostic.com/?irclickid=… Use Code: CONQUERAGING NAD+ Quantification: https://www.jinfiniti.com/intracellul… Use Code: ConquerAging At Checkout Oral Microbiome: https://www.bristlehealth.com/?ref=mi… Enter Code: ConquerAging SiphoxHealth Blood Testing (ApoB, GrimAge): https://siphoxhealth.com/mlustgarten Green Tea: https://www.ochaandco.com/?ref=fqbtflod Use Code: ML10OFF Diet Tracking: https://shareasale.com/r.cfm?b=139013… If you’d like to support the channel, you can do that with the website, Buy Me A Coffee: https://www.buymeacoffee.com/mlhnrca Conquer Aging Or Die Trying Merch! https://my-store-d4e7df.creator-sprin…

Blood Testing Essentials (Biological Age, CVD-Risk, Kidney Health and Function):
PhenoAge (Biological Age): https://www.ultalabtests.com/partners…

Measure the Bortz biological clock biomarkers: https://www.ultalabtests.com/partners…

Calculate your biological age using the Bortz clock: https://www.longevity-tools.com/human…

Light-triggered arrhythmia reveals rapid brain oxygen shifts in mice

An irregular heartbeat, or arrhythmia, leads to inefficient pumping of blood by the heart, which then prevents blood and oxygen from getting to the body’s other organs. When blood and oxygen flow poorly to the brain, the risk of stroke and cognitive decline increases.

A team of researchers based at Washington University in St. Louis used cardiac optogenetics to noninvasively study arrhythmia and its impact on the brain. Using highly sensitive imaging in a mouse model, they found that arrhythmia in a mouse heart alters oxygen concentration in the brain during and after arrhythmia.

Results of the research are published in Science Advances.

Fragile X deficits in mice respond to gene therapy

A gene therapy designed to replace a missing brain protein restored normal brain activity and improved behavior in a mouse model of fragile X syndrome (FXS), according to a study led by researchers at the University of California, Riverside. The findings, published in Molecular Therapy Nucleic Acids, suggest that gene therapy may one day address the underlying cause of FXS rather than simply treating its symptoms.

FXS affects approximately 2–3% of individuals diagnosed with autism and is one of the best-defined genetic causes of neurodevelopmental disability. The condition occurs when a mutation in the FMR1 gene prevents the production of fragile X messenger ribonucleoprotein (FMRP), a protein that regulates communication between brain cells.

“In a typical brain, FMRP acts like a brake or a volume control,” said Iryna Ethell, the paper’s senior author and a professor of biomedical sciences in the UCR School of Medicine. “Without it, neural circuits become overactive and less efficient, which contributes to many of the developmental and behavioral challenges associated with FXS.”

Scientists uncover a genetic ‘shield’ that lowers the risk of colorectal cancer

A team of scientists from the Barbara Ann Karmanos Cancer Institute, Wayne State University and institutions across the U.S. have published a new paper on the role of TGFBR1*6A, a naturally occurring genetic mutation in the TGFBR1 gene found in approximately 14% of the general population.

The study, “TGFBR1*6A and risk for colorectal cancer,” published June 9, 2026, in Cancer Communications, focuses on TGFBR1*6A and how it influences a person’s risk of developing colorectal cancer. Dr. Boris Pasche, president and CEO of the Karmanos Cancer Institute and chair of the Wayne State University Department of Oncology, was the first to discover TGFBR1*6A as a cancer risk allele.

“This mutation has often been overlooked by genome-wide association study chips, which cannot detect TGFBR1*6A, and is commonly missed by next-generation sequencing platforms due to the complexity of the region,” said Dr. Allan Johansen, a postdoctoral fellow and first author of the paper.

/* */